Crescent Biopharma, Inc.
Crescent Biopharma, Inc. (CBIO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CBIO · as of Jun 9, 2026
Key Statistics
Explore Crescent Biopharma, Inc. Data
cbio stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 13 · Buy rate: 61.5%
The CBIO analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month price target is $33.00, representing +90.97% upside from the current price of $17.28.
Competitors & Peers
cbio competitorsCBIO
ARMP
CCCC
CGEN
HIND
HRTXStock Performance
Full HistoryAbout Crescent Biopharma, Inc.
Crescent Biopharma, Inc. is a biotechnology firm dedicated to the research and development of novel cancer therapies. Its investigational portfolio notably includes CR-001, a proprietary bispecific an…
what is crescent biopharma, inc. · cbio stock overview · crescent biopharma, inc. company profile · who is crescent biopharma, inc. ceo · cbio NASDAQ · crescent biopharma, inc. headquarters · crescent biopharma, inc. business segments
About Stock Overview & Key Data
Crescent Biopharma, Inc. (CBIO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 10, 2014. As of the latest trading session, CBIO stock price is $17.28, with a market capitalization of $476.4M. The stock has returned -2.15% over the past 12 months and +45.70% year-to-date.
According to 13 Wall Street analysts, the consensus rating for Crescent Biopharma, Inc. stock is Buy, with an average 12-month price target of $33.00. In fiscal year 2025, Crescent Biopharma, Inc. reported revenue of $10.8M and net income of -$153.9M. For detailed data — including Crescent Biopharma, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Crescent Biopharma, Inc. (CBIO) stock price is $17.28. The stock is traded on NASDAQ under the ticker symbol CBIO. The 52-week range is $8.72 – $27.41.